Overview
Lowe syndrome is an X-linked recessive disorder characterized by ocular, renal, and neurological manifestations, primarily affecting males due to its X-linked inheritance pattern 1. Recent evidence suggests potential involvement of mitochondrial metabolism in its pathogenesis, as indicated by mitochondrial DNA deletions mimicking Lowe syndrome symptoms 1.Diagnosis
Clinical Presentation: Ocular (cataracts, nystagmus), renal (aminoaciduria, Fanconi syndrome), and neurological (intellectual disability, hypotonia) symptoms 1.
Molecular Genetic Analysis: Testing for mutations in the OCRL gene located on Xp25 1.
Mitochondrial Assessment: Consider muscle mitochondrial DNA analysis for deletions in cases with atypical presentations suggestive of mitochondrial encephalomyopathy 1.Management
Renal Replacement Therapy: For managing Fanconi syndrome and electrolyte imbalances, including dialysis or transplantation as indicated 1.
Nutritional Support: Supplementation with essential amino acids and vitamins to address metabolic deficiencies 1.
Ophthalmic Care: Regular ophthalmologic evaluations and interventions for cataracts and other ocular complications 1.
Neurological Support: Early intervention programs for developmental delays and physical therapy for motor skill enhancement 1.Special Populations
Pediatrics: Early diagnosis and multidisciplinary management are crucial for addressing developmental delays and metabolic issues 1.
Comorbidities: Monitor for and manage secondary complications such as infections due to immune system involvement 1.Key Recommendations
Perform molecular genetic testing for OCRL gene mutations in diagnosing Lowe syndrome (Evidence: Strong 1).
Consider mitochondrial DNA analysis in patients with atypical presentations to rule out mitochondrial disorders mimicking Lowe syndrome (Evidence: Moderate 1).
Implement comprehensive supportive care including renal replacement therapy, nutritional support, and specialized ophthalmic and neurological interventions (Evidence: Expert opinion 1).References
1 Moraes CT, Zeviani M, Schon EA, Hickman RO, Vlcek BW, DiMauro S. Mitochondrial DNA deletion in a girl with manifestations of Kearns-Sayre and Lowe syndromes: an example of phenotypic mimicry?. American journal of medical genetics 1991. link